This $91 Million Position Signals Conviction in a Biotech Stock Eyeing FDA Decision This Year
Vera Therapeutics(US:VERA) Yahoo Finance·2026-03-21 02:09On February 17, 2026, Integral Health Asset Management disclosed a buy of 100,000 Vera Therapeutics (NASDAQ:VERA) shares, an estimated $3.55 million trade based on quarterly average pricing. What happened According to a Securities and Exchange Commission (SEC) filing dated February 17, 2026, Integral Health Asset Management increased its position in Vera Therapeutics by 100,000 shares. The estimated value of this trade, based on the average closing price for the quarter ending December 31, 2025, is $3.55 ...